farmaco semaglutide FDA issues warning about some compounded versions of for diabetes, weight loss Month program now available from Weight Care Weight Management for Adults with

According to reports by the National Practitioner Data Bank, between 1990 and 2025, the state of Michigan has seen 43,361 Adverse Action Reports (AARs) and 21,485 Medical Malpractice Payment Reports (MMPRs)

Oral Wegovy: Semaglutide Pill FDA-approved in December 2025, the Wegovy pill offers a daily oral option for weight management, offering the same effective GLP-1 science found in injectable Wegovy

Important: Semaglutide is contraindicated in patients with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN2), and is not recommended during pregnancy, especially when used for weight management

Common Side Effects Nausea and vomiting: The most frequently reported effects, especially at the beginning of treatment